Overall, elevated levels of IL-8 in cancer patients typically align with advanced tumor stage, higher grading, and increased tumor burden, and seem to be predictive for resistance to immune checkpoint inhibitors (68, 69). This evidence concerns the gene CXCL8 and cancer.